Documentos clave

Ver Toda la documentación

Saltar a

SML0010

LY-334370 hydrochloride hydrate

Name: LY-334370 hydrochloride hydrate
Brand: SIGMA

≥98% (HPLC), powder

Sinónimos:

4-Fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide hydrochloride hydrate

Iniciar sesión para ver los precios por organización y contrato.

Acerca de este artículo

Fórmula empírica (notación de Hill):

C₂₁H₂₂FN₃O · HCl · xH₂O

Número CAS:

199673-74-0

Peso molecular:

387.88 (anhydrous basis)

NACRES:

NA.77

PubChem Substance ID:

329825086

UNSPSC Code:

12352202

MDL number:

MFCD11519957

Assay:

≥98% (HPLC)

Form:

powder

Este producto está descatalogado. Póngase en contacto con el Servicio técnicopara asistencia

Propiedades

assay

≥98% (HPLC)

form

powder

color

white to tan

solubility

H₂O: ≥5 mg/mL (warmed)

originator

Eli Lilly

storage temp.

2-8°C

SMILES string

Cl.CN1CCC(CC1)c2c[nH]c3ccc(NC(=O)c4ccc(F)cc4)cc23

InChI

1S/C21H22FN3O.ClH/c1-25-10-8-14(9-11-25)19-13-23-20-7-6-17(12-18(19)20)24-21(26)15-2-4-16(22)5-3-15;/h2-7,12-14,23H,8-11H2,1H3,(H,24,26);1H

InChI key

DGPDGAPZTPSHBL-UHFFFAOYSA-N

Descripción

Application

LY-334370 hydrochloride hydrate may be used to study 5-HT 1F-mediated cell signaling.

Biochem/physiol Actions

LY-334370 hydrochloride is a selective 5-HT1F receptor agonist.

LY-334370 modulates the transmission in the mouse trigeminal system and inhibits the neuronal responses within rat Sp5C by inhibiting c-Fos activation. It shows efficacy in aborting migraine attacks.[1][2]

Features and Benefits

This compound was developed by Eli Lilly. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Clase de almacenamiento

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

041M4626V

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

Busque por un COA

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Novel potent 5-HT(1F) receptor agonists: structure-activity studies of a series of substituted N-[3-(1-methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides.

Sandra A Filla et al.

Journal of medicinal chemistry, 46(14), 3060-3071 (2003-06-27)

Compound 1a (LY334370), a selective 5-HT(1F) receptor agonist (SSOFRA), inhibited dural inflammation in the neurogenic plasma protein extravasation model of migraine and demonstrated clinical efficacy for the acute treatment of migraine. Although 1a was greater than 100-fold selective over both

5-Hydroxytryptamine(1B/1D) and 5-hydroxytryptamine1F receptors inhibit capsaicin-induced c-fos immunoreactivity within mouse trigeminal nucleus caudalis.

D D Mitsikostas et al.

Cephalalgia : an international journal of headache, 22(5), 384-394 (2002-07-12)

In order to investigate the c-fos response within the trigeminal nucleus caudalis (Sp5C) after noxious meningeal stimulation, capsaicin (0.25, 0.5, 1 and 5 nmol) was administered intracisternally in urethane (1 g/kg) and alpha-chloralose (20 mg/kg) anaesthetized male mice. Capsaicin induced

Número de artículo de comercio global

SKU	GTIN
SML0010-5MG	04061837076565
SML0010-25MG	04061832074597

Questions

Reviews

No rating value